case report aspiration during anesthesia glp-1 receptor agonist 2023 How should agonists be managed in the perioperative period? A Scoping Review of GLP-1

Description

2) a low risk of contributing to hypoglycemic events

Conclusions GLP-1 agonists reduce fetal survival, weight, growth and skeletal ossification and can induce major congenital anomalies

Setting expectations for each phase prevents discouragement when the pace naturally changes

The novel GLP-1 receptor agonist (Ex-4)2-Fc, developed by Zhou et al., demonstrated anti-inflammatory activity in their study

10.1124/jpet.111.181529 [DOI] [PubMed] [Google Scholar] 88.Ponirakis G, Abdul-Ghani MA, Jayyousi A, Zirie MA, Qazi M, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, Al-Mohannadi S, AlMarri F, Al-Khayat F, Mahfoud Z, Al Hamad H, Ramadan M, DeFronzo R, Malik RA (2021) Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control